Close Menu


Integriderm, of Huntsville, Alabama, together with its partner Invitrogen, has launched PharmArray, a new microarray with genes specifically selected for toxicology and pharmacology research on ADME (absorption, distribution, m

AT A GLANCE Received his master’s degree in electrical engineering in 1990 from Manhattan College. Formerly designed radar systems for tracking aircraft and missile guidance.

Illumina and GlaxoSmithKline have signed an agreement in which Illumina will use its BeadArray technology to determine the frequency of specific SNPs in a set of samples that Glaxo provides.

Microfluidics maker Fluidigm has signed a collaboration with Axon Instruments to develop a cell capture and manipulation microfluidics chip for drug discovery, the company said.

BioArray Solutions, Vysis


BioArray Solutions, of Piscataway, NJ, received US Patent Number 6,251,691 for a method of assembling biomolecules on a flat surface using light-controlled electrokinetic forces.

With a newly granted patent and a newly published article validating its protein binding technology, Lexington, Mass.-based Phylos is readying to attack the protein chip market.

University of Alabama researcher David Allison is organizing a retreat using a $409,000 Research Coordination Network (RCN) grant he just received from the National Science Foundation to form a national microarray data analysis research network.

To tackle the mountain of issues involved in microarray data analysis, David Allison, a biostatistician from the University of Alabama at Birmingham, is bringing together a diverse group of researchers for a retreat at Mohonk Mountain House in New Paltz, NY, from September 10 through 13.

Qiagen has signed on Aventis Pharma as its first technology access partner for its new ZeptoGene Workstation microarray platform.

PATENT WATCH: Jun 29, 2001


Qiagen was awarded US Patent Number 6,248,521 for a method of amplifying oligonucleotides onto a flat substrate such as a glass slide or silicon wafer.


Pfizer and BioNTech announce they are seeking FDA authorization for their candidate SARS-CoV-2 vaccine.

Science has retracted a 2007 paper from a former Dutch minister and his colleagues, according to Retraction Watch.

The New York Times reports that a plan to cull minks in Denmark to prevent the spread of a new SARS-CoV-2 strain led to calls for the prime minister's resignation.

In Science this week: winner of the Science & SciLifeLab Prize for Young Scientists, and more.